Q2

Jeremiah's Italian Ice Celebrates Successful Q3 Heading into Year End

Retrieved on: 
Tuesday, November 7, 2023
QSR, Restaurant, Holiday, The World's 50 Best Restaurants, Entrepreneurship, Dancing on Ice (franchise), Q3, Growth, City, Pumpkin pie, Q2

ORLANDO, Fla., Nov. 7, 2023 /PRNewswire/ -- Jeremiah's Italian Ice – the hottest brand in the frozen dessert category – has seen tremendous growth in the third quarter of 2023 as the demand for the brand continues to rise., Jeremiah's is humbled by the growth they've seen so far and anticipates a busy end of the year as they keep up with consumer and franchisee demand.

Key Points: 
  • Having opened 18 new locations across Q1 and Q2, the Italian Ice brand opened an impressive 12 additional locations in the last three months while also awarding agreements for an additional 20 new units.
  • "Jeremiah's is incredibly lucky to partner with passionate franchisees that are committed to our mission," said Michael Keller, CEO and President of Jeremiah's.
  • The brand was also recognized on QSR's Best Brands to Watch and QSR's 17 Best Restaurants for Franchising lists.
  • To learn more about Jeremiah's Italian Ice, or its franchise opportunities, please visit: https://jeremiahsfranchise.com/.

Calibre Reports Strong Third Quarter Financial Results: Increasing Free Cash Flow From a Fourth Consecutive Quarter of Record Gold Production at 73,485 Ounces, Resulting in a Record Year To Date Earnings of US$0.16 Per Share

Retrieved on: 
Tuesday, November 7, 2023
Consolidated, Gold, Pan, Sierra Atravesada, OTCQX, Bank statement, AISC, Growth, Net, TSX, CXB, TCC, Palladium, Reinsurance, Mining, Printed circuit board, Q2, Caliber

Consolidated financial statements and management discussion and analysis can be found at www.sedarplus.ca and the Company’s website, www.calibremining.com .

Key Points: 
  • Consolidated financial statements and management discussion and analysis can be found at www.sedarplus.ca and the Company’s website, www.calibremining.com .
  • Darren Hall, President and Chief Executive Officer of Calibre, stated: “Calibre generated strong free cash flow from a fourth consecutive quarter of record production, resulting in a 72% increase in cash on hand to $97 million since the beginning of the year.
  • The Company continues to self fund all exploration and growth from operating cash flow while increasing our cash reserves.
  • Our ongoing incorporation of sustainability initiatives throughout our operations further solidifies our strong social license to operate.”

FMC Corporation (FMC) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys

Retrieved on: 
Tuesday, November 7, 2023
Q2, Person, Growth, Hagens Berman, FY, FMC Corporation, Patent, FMC, Pharmaceutical industry, Life insurance

On May 1, 2023, FMC announced its Q1 2023 financial results, said Q2 2023 revenue would be flat to the prior year quarter, and maintained FY 2023 revenue outlook of $6.08 to $6.22 billion.

Key Points: 
  • On May 1, 2023, FMC announced its Q1 2023 financial results, said Q2 2023 revenue would be flat to the prior year quarter, and maintained FY 2023 revenue outlook of $6.08 to $6.22 billion.
  • But, on July 10, 2023, FMC announced updated expectations for its Q2 and FY 2023 outlook.
  • “We’re focused on investors’ losses and are investigating whether FMC may have misrepresented its sales and inventory management practices and the strength of certain patent protections,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights

Retrieved on: 
Monday, November 6, 2023
Complete Response Letter, COGS, CCR8, FDA, Element, Research, Sale, IND, Food, PIN, Biologics license application, Medicare, SG, Cisplatin, Injector, Symantec Endpoint Protection, Surface, Conference, PD-1, GAAP, CHRS, Acquisition, HIV disease progression rates, Exercise, NPC, R, CRL, Adalimumab, Ranibizumab, Neoplasm, Risk, Webcast, Tumor microenvironment, Conference call, Investment, IL-27, BLA, Investigational New Drug, Rare-earth element, Video game, Pharmaceutical industry, Medical device, Online shopping, Q2

REDWOOD CITY, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today reported financial results for the quarter ended September 30, 2023, and recent business highlights:

Key Points: 
  • – Conference call today at 5:00 p.m. Eastern Time –
    REDWOOD CITY, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today reported financial results for the quarter ended September 30, 2023, and recent business highlights:
    CIMERLI® (ranibizumab-eqrn) net product sales increased in the third quarter 2023 to $40.0 million compared to $26.7 million in the second quarter.
  • UDENYCA® (pegfilgrastim-cbqv) net product sales increased in the third quarter 2023 to $33.0 million compared to $31.7 million in the second quarter.
  • Market share grew to 16.5% in the third quarter 2023, an increase of 4.3 market share percentage points compared to the prior quarter.
  • Coherus anticipates demand will continue to rise with significantly improved commercial and Medicare Advantage formulary coverage in the fourth quarter of 2023 and in 2024.

“FMC Corporation (FMC) Warns of Revenue Shortfall After Blue Orca Shorts Company for Concealing Competitive Risks,” Hagens Berman

Retrieved on: 
Thursday, November 2, 2023
Person, FMC Corporation, FY, NYSE, Patent, Q2, Growth, Hagens Berman, FMC, SAN, Life insurance, Beauty salon, Pharmaceutical industry

SAN FRANCISCO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges FMC Corporation (NYSE: FMC) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges FMC Corporation (NYSE: FMC) investors who suffered substantial losses to submit your losses now .
  • The investigation focuses on the propriety of FMC’s sales and inventory management practices, and on the sustainability of growth and financial results flowing from its patented diamide insect control products.
  • On May 1, 2023, FMC announced its Q1 2023 financial results, said Q2 2023 revenue would be flat to the prior year quarter, and maintained FY 2023 revenue outlook of $6.08 to $6.22 billion.
  • But, on July 10, 2023, FMC announced updated expectations for its Q2 and FY 2023 outlook.

Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results

Retrieved on: 
Thursday, November 2, 2023
NYSE, International, Health care, OTC, Share repurchase, PBH, Growth, EPS, Prestige Consumer Healthcare, Dermatology, Cold, Clothing, Drug, Pharmaceutical industry, Q2

Second Fiscal Quarter Ended September 30, 2023

Key Points: 
  • Second Fiscal Quarter Ended September 30, 2023
    Reported revenues in the second quarter of fiscal 2024 of $286.3 million compared to a record $289.3 million in the second quarter of fiscal 2023.
  • Reported net income for the second quarter of fiscal 2024 totaled $53.6 million, compared to the prior year second quarter’s net income of $51.0 million.
  • Non-GAAP free cash flow in the second quarter of fiscal 2024 was $59.5 million compared to $55.2 million in the prior year second quarter.
  • International OTC Healthcare: Fiscal second quarter 2024 segment revenues were $41.9 million compared to $37.2 million reported in the prior year comparable period.

Aware® Reports Third Quarter and Nine Month 2023 Financial Results

Retrieved on: 
Wednesday, November 1, 2023
Sale, AWRE, ARR, High, FATE, Government, National Institute of Standards and Technology, EBITDA, VARS, Federation, Acquisition, Eckel, Data science, Maintenance, Artificial intelligence, Growth, Machine learning, Share repurchase, Traction, Algorithm, PAD, Software as a service, Clothing, Cryptocurrency, Video game, Rare-earth element, Pharmaceutical industry, Bookkeeping, Q2, BURLINGTON

BURLINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Aware, Inc. (NASDAQ: AWRE), a global biometric platform company that uses data science, machine learning, and artificial intelligence to tackle everyday business and identity challenges through biometrics, today reported financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Total revenue for the third quarter of 2023 increased 112% to $6.4 million compared to $3.0 million in the third quarter of 2022.
  • Operating cashflow for the third quarter of 2023 totaled $2.5 million, compared to cash usage of $2.0 million in the same year-ago period.
  • Net income for the third quarter of 2023 totaled $1.1 million, or $0.05 per diluted share.
  • Adjusted EBITDA (a non-GAAP metric reconciled below) for the third quarter of 2023 totaled $0.4 million.

Sunrun Reports Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 1, 2023
Asset, Solar energy, Vivint Solar, Solar System, PG, ITC, Acquisition, CockroachDB, Tesla Energy, Customer, Artificial intelligence, Growth, Revenue stream, Machine learning, Head, A-1, CO2, PG&E, Generation, SAN, Renewable energy, Reinsurance, Airline, Mobile phone, Video game, Subscription business model, Q2, Sunrun, Q3

Customers grew 19% in the third quarter of 2023 compared to the third quarter of 2022.

Key Points: 
  • Customers grew 19% in the third quarter of 2023 compared to the third quarter of 2022.
  • Total revenue was $563.2 million in the third quarter of 2023, down $68.7 million, or 11%, from the third quarter of 2022.
  • During the third quarter of 2023, Sunrun recorded a non-cash goodwill impairment charge of approximately $1.2 billion.
  • Sunrun is hosting a conference call for analysts and investors to discuss its third quarter 2023 results and business outlook at 2:00 p.m. Pacific Time today, November 1, 2023.

Malware ‘Meal Kits’ Are Helping Attackers Steal Businesses’ Lunch, HP Finds

Retrieved on: 
Tuesday, October 31, 2023
PDF, HP Inc., HP, NYSE, PALO, HPQ, Research, JavaScript, Archive, Microsoft PowerPoint, Harry Houdini, Risk, Parallax, USD, GitHub, VBScript, Infection, Online shopping, Risk management, Cryptocurrency, Pharmaceutical industry, Q2, Microsoft Excel, Q3

Based on data from millions of endpoints running HP Wolf Security, key findings include:

Key Points: 
  • Based on data from millions of endpoints running HP Wolf Security, key findings include:
    Houdini’s Last Act: A new campaign targeted businesses with fake shipping documents concealing Vjw0rm JavaScript malware.
  • Cybercriminals Deploy “Jekyll and Hyde” Attacks: HP discovered a Parallax RAT campaign launching two threads when a user opens a malicious scanned invoice designed to trick users.
  • Alex Holland, Senior Malware Analyst in the HP Wolf Security threat research team, comments:
    "Threat actors today can easily purchase pre-packaged, user-friendly malware ‘meal kits’, that infect systems with a single click.
  • Other findings include:
    Archives were the most popular malware delivery type for the sixth quarter running, used in 36% of cases analyzed by HP.

FMC Corporation (FMC) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys

Retrieved on: 
Monday, October 30, 2023
Q2, Person, Growth, Hagens Berman, FY, FMC Corporation, Patent, FMC, Pharmaceutical industry, Life insurance

On May 1, 2023, FMC announced its Q1 2023 financial results, said Q2 2023 revenue would be flat to the prior year quarter, and maintained FY 2023 revenue outlook of $6.08 to $6.22 billion.

Key Points: 
  • On May 1, 2023, FMC announced its Q1 2023 financial results, said Q2 2023 revenue would be flat to the prior year quarter, and maintained FY 2023 revenue outlook of $6.08 to $6.22 billion.
  • But, on July 10, 2023, FMC announced updated expectations for its Q2 and FY 2023 outlook.
  • “We’re focused on investors’ losses and are investigating whether FMC may have misrepresented its sales and inventory management practices and the strength of certain patent protections,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.